<!doctype html><html lang=fr><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>MOUNJARO : nouveau m√©dicament injectable indiqu√© dans le traitement du diab√®te de type 2 et de l'ob√©sit√© | Mounjaro News</title><meta name=description content="Le Mounjaro repr√©sente une avanc√©e th√©rapeutique significative dans la prise en charge de deux conditions m√©taboliques majeures."><meta name=author content="Mounjaro News"><meta name=keywords content="Mounjaro,tirz√©patide,tirzepatide,GLP-1,MOUNJARO : nouveau m√©dicament injectable indiqu√© dans le traitement du diab√®te de type 2 et de l'ob√©sit√©"><meta name=robots content="index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1"><meta name=language content="fr"><meta name=revisit-after content="1 day"><link rel=canonical href=https://mounjaronews.info/posts/2026-03-01-mounjaro-nouveau-medicament-injectable-indique-dans-le-trait/><link rel=alternate hreflang=fr href=https://mounjaronews.info/posts/2026-03-01-mounjaro-nouveau-medicament-injectable-indique-dans-le-trait/><link rel=alternate hreflang=en href=https://mounjaronews.info/posts/2026-03-01-mounjaro-nouveau-medicament-injectable-indique-dans-le-trait/><link rel=alternate hreflang=x-default href=https://mounjaronews.info/><meta property="og:site_name" content="Mounjaro News"><meta property="og:title" content="MOUNJARO : nouveau m√©dicament injectable indiqu√© dans le traitement du diab√®te de type 2 et de l'ob√©sit√© | Mounjaro News"><meta property="og:description" content="Le Mounjaro repr√©sente une avanc√©e th√©rapeutique significative dans la prise en charge de deux conditions m√©taboliques majeures."><meta property="og:url" content="https://mounjaronews.info/posts/2026-03-01-mounjaro-nouveau-medicament-injectable-indique-dans-le-trait/"><meta property="og:locale" content="fr_FR"><meta property="og:locale:alternate" content="en_US"><meta property="og:type" content="article"><meta property="article:published_time" content="2026-03-01T18:17:59+01:00"><meta property="article:modified_time" content="2026-03-01T18:17:59+01:00"><meta property="article:author" content="Mounjaro News"><meta property="article:section" content="Sant√© / Health"><meta property="article:tag" content="Mounjaro"><meta property="article:tag" content="Tirz√©patide"><meta property="article:tag" content="GLP-1"><meta property="article:tag" content="Diab√®te"><meta property="article:tag" content="Perte de poids"><meta name=twitter:card content="summary_large_image"><meta name=twitter:title content="MOUNJARO : nouveau m√©dicament injectable indiqu√© dans le traitement du diab√®te de type 2 et de l'ob√©sit√© | Mounjaro News"><meta name=twitter:description content="Le Mounjaro repr√©sente une avanc√©e th√©rapeutique significative dans la prise en charge de deux conditions m√©taboliques majeures."><script type=application/ld+json>{"@context":"https://schema.org","@type":"WebSite","name":"Mounjaro News","url":"https:\/\/mounjaronews.info\/","description":"Toute l\u0027actualit√© du Mounjaro (tirz√©patide) ‚Äî articles reformul√©s et traduits chaque jour par IA","inLanguage":["fr-FR","en-US"],"about":{"@type":"Drug","name":"Tirzepatide","alternateName":["Mounjaro","Zepbound"],"sameAs":"https://www.wikidata.org/wiki/Q113523571"}}</script><script type=application/ld+json>{"@context":"https://schema.org","@type":"NewsArticle","headline":"\"MOUNJARO : nouveau m√©dicament injectable indiqu√© dans le traitement du diab√®te de type 2 et de l'ob√©sit√©\"","description":"\"Le Mounjaro repr√©sente une avanc√©e th√©rapeutique significative dans la prise en charge de deux conditions m√©taboliques majeures.\"","datePublished":"2026-03-01T18:17:59\u002b01:00","dateModified":"2026-03-01T18:17:59\u002b01:00","inLanguage":["fr-FR","en-US"],"author":{"@type":"Organization","name":"Mounjaro News","url":"https:\/\/mounjaronews.info\/"},"publisher":{"@type":"Organization","name":"Mounjaro News","url":"https:\/\/mounjaronews.info\/"},"mainEntityOfPage":{"@type":"MedicalWebPage","@id":"https:\/\/mounjaronews.info\/posts\/2026-03-01-mounjaro-nouveau-medicament-injectable-indique-dans-le-trait\/","medicalAudience":{"@type":"MedicalAudience","audienceType":"Patient"}},"about":{"@type":"Drug","name":"Tirzepatide","alternateName":"Mounjaro"},"isBasedOn":{"@type":"NewsArticle","url":"\"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNbmNYM0VCRFBnb0VzMm5uVElReTdXMWJEUXFpdGhPNjJjM2MwQUF2LTB4cTlPZmtJTFFMdmcxTlNEWU1OMmhZVmttZ0ZkaHJMNjFtd1gzR0VLdXJ6TnZtU1JRUkwtVzdpSHlsZDJaaE5kQUNaYm9JUnBWMjlsdDR0WGgxMnlzQldUX0FNQ0ZzWGxWSzViak1NMk1IOFRNc2t4WGNXT21BVno2dlNOaHBZZTJXUGxLM3VPU2lpa1M1Y1U5YmJyQVYtNklHOUNwcXBxYkVSTHJFdFJSUkZPUGc?oc=5\""}}</script><script type=application/ld+json>{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mounjaronews.info\/"},{"@type":"ListItem","position":2,"name":"\"MOUNJARO : nouveau m√©dicament injectable indiqu√© dans le traitement du diab√®te de type 2 et de l'ob√©sit√©\"","item":"https:\/\/mounjaronews.info\/posts\/2026-03-01-mounjaro-nouveau-medicament-injectable-indique-dans-le-trait\/"}]}</script><link rel=preconnect href=https://fonts.googleapis.com><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800;900&display=swap" rel=stylesheet><link rel=stylesheet href=/css/style.css><script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-4796217302525352" crossorigin=anonymous></script><script async src=https://subscribe-forms.beehiiv.com/embed.js></script><link rel=icon type=image/svg+xml href="data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 100 100'><rect width='100' height='100' rx='20' fill='%232563eb'/><text y='68' x='50' text-anchor='middle' font-size='38' font-family='system-ui' font-weight='800' fill='white'>MNJ</text></svg>"></head><body><header class=site-header><nav class=site-nav><a href=/ class=site-logo><div class=logo-icon>MNJ</div><div class=logo-text><span class=logo-name>Mounjaro News</span>
<span class=logo-sub>Actualit√©s tirz√©patide ¬∑ FR & EN</span></div></a><ul class=nav-links><li><a href=/>Accueil</a></li><li><a href=https://www.mounjaro.com target=_blank rel=noopener>Mounjaro.com</a></li><li><a href=/#newsletter class=nav-pill>Newsletter gratuite</a></li></ul></nav></header><div class=article-header><div class=article-header-inner><a href=/ class=back-link>‚Üê Retour ¬∑ Back</a><div class=article-label>üíä Mounjaro ¬∑ Tirz√©patide</div><h1>MOUNJARO : nouveau m√©dicament injectable indiqu√© dans le traitement du diab√®te de type 2 et de l'ob√©sit√©</h1><div class=article-meta><span class=meta-chip>üìÖ 1 March 2026</span>
<span class=meta-chip>üì∞ news.google.com</span>
<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxNbmNYM0VCRFBnb0VzMm5uVElReTdXMWJEUXFpdGhPNjJjM2MwQUF2LTB4cTlPZmtJTFFMdmcxTlNEWU1OMmhZVmttZ0ZkaHJMNjFtd1gzR0VLdXJ6TnZtU1JRUkwtVzdpSHlsZDJaaE5kQUNaYm9JUnBWMjlsdDR0WGgxMnlzQldUX0FNQ0ZzWGxWSzViak1NMk1IOFRNc2t4WGNXT21BVno2dlNOaHBZZTJXUGxLM3VPU2lpa1M1Y1U5YmJyQVYtNklHOUNwcXBxYkVSTHJFdFJSUkZPUGc?oc=5" target=_blank rel="noopener noreferrer" class=source-link>üîó Source originale</a></div></div></div><div class=article-body><div class=ad-wrapper><p class=ad-label>Publicit√©</p><ins class=adsbygoogle style=display:block;text-align:center data-ad-layout=in-article data-ad-format=fluid data-ad-client=ca-pub-4796217302525352 data-ad-slot=auto></ins><script>(adsbygoogle=window.adsbygoogle||[]).push({})</script></div><div class=lang-switcher id=langSwitcher><button class="lang-btn active" data-lang=fr onclick='switchLang("fr")'>
üá´üá∑ Fran√ßais
</button>
<button class=lang-btn data-lang=en onclick='switchLang("en")'>
üá¨üáß English</button></div><div class=bilingual-grid><div class=lang-block id=block-fr><div class=lang-header><span class=lang-flag>üá´üá∑</span> Version fran√ßaise</div><div class=lang-content>Le Mounjaro repr√©sente une avanc√©e th√©rapeutique significative dans la prise en charge de deux conditions m√©taboliques majeures. Ce m√©dicament injectable contient la tirz√©patide, une mol√©cule qui agit selon un m√©canisme dual innovant. Contrairement aux traitements GLP-1 traditionnels, la tirz√©patide active deux r√©cepteurs distincts : celui du GLP-1 et celui du GIP. Cette double action amplifie les effets b√©n√©fiques sur la r√©gulation du glucose sanguin et la sensation de sati√©t√©. Initialement d√©velopp√© pour le diab√®te de type 2, le Mounjaro a d√©montr√© son efficacit√© dans la r√©duction du poids corporel, ouvrant des perspectives dans le traitement de l&rsquo;ob√©sit√©. Les donn√©es cliniques montrent une am√©lioration significative du contr√¥le glyc√©mique et une diminution du poids chez les patients trait√©s. L&rsquo;administration se fait par injection sous-cutan√©e hebdomadaire, offrant une commodit√© th√©rapeutique appr√©ciable. Comme tous les m√©dicaments, le Mounjaro pr√©sente un profil de tol√©rance √† consid√©rer, avec des effets ind√©sirables potentiels √† documenter. Son arriv√©e sur le march√© repr√©sente une option suppl√©mentaire pour les professionnels de sant√© cherchant √† adapter leurs strat√©gies th√©rapeutiques aux besoins individuels des patients atteints de ces pathologies chroniques.</div></div><div class=lang-block id=block-en><div class=lang-header><span class=lang-flag>üá¨üáß</span> English version</div><div class=lang-content>Mounjaro represents a significant therapeutic breakthrough in managing two major metabolic disorders. This injectable medication contains tirzepatide, a molecule that operates through an innovative dual mechanism. Unlike traditional GLP-1 treatments, tirzepatide activates two distinct receptors: the GLP-1 receptor and the GIP receptor. This dual action amplifies beneficial effects on blood glucose regulation and satiety sensation. Originally developed for type 2 diabetes management, Mounjaro has demonstrated considerable effectiveness in reducing body weight, opening new perspectives for obesity treatment. Clinical data reveal substantial improvements in glycemic control and weight reduction among treated patients. Administration occurs through weekly subcutaneous injection, offering valuable therapeutic convenience. Like all medications, Mounjaro carries a tolerability profile requiring consideration, with potential side effects requiring documentation. Its market arrival represents an additional option for healthcare professionals seeking to customize therapeutic strategies according to individual patient needs affected by these chronic conditions. This development reflects ongoing advances in metabolic disease management.</div></div></div><div class=ad-wrapper><p class=ad-label>Publicit√©</p><ins class=adsbygoogle style=display:block;text-align:center data-ad-layout=in-article data-ad-format=fluid data-ad-client=ca-pub-4796217302525352 data-ad-slot=auto></ins><script>(adsbygoogle=window.adsbygoogle||[]).push({})</script></div><div class=newsletter-section><div class=newsletter-inner><div class=newsletter-icon>üì¨</div><h3>Recevez l'actu Mounjaro chaque matin</h3><p>Abonnez-vous gratuitement ‚Äî r√©sum√© quotidien FR & EN dans votre bo√Æte mail.
<em>Subscribe free ‚Äî daily FR & EN digest in your inbox.</em></p><iframe src=https://subscribe-forms.beehiiv.com/91587c2f-9b1e-45e3-95cf-1f8ca0fe3c4b class=beehiiv-embed data-test-id=beehiiv-embed frameborder=0 scrolling=no></iframe></div></div></div><script>function switchLang(e){const t=window.innerWidth<=700;if(!t)return;document.querySelectorAll(".lang-btn").forEach(t=>{t.classList.toggle("active",t.dataset.lang===e)}),document.getElementById("block-fr").style.display=e==="fr"?"":"none",document.getElementById("block-en").style.display=e==="en"?"":"none"}window.innerWidth<=700&&(document.getElementById("block-en").style.display="none"),window.addEventListener("resize",function(){window.innerWidth>700&&(document.getElementById("block-fr").style.display="",document.getElementById("block-en").style.display="")})</script><footer class=site-footer><div class=footer-inner><div class=footer-grid><div class=footer-brand><a href=/ class=site-logo><div class=logo-icon>MNJ</div><div class=logo-text><span class=logo-name style=color:rgba(255,255,255,.9)>Mounjaro News</span>
<span class=logo-sub>Actualit√©s tirz√©patide ¬∑ FR & EN</span></div></a><p style=margin-top:14px>R√©sum√©s quotidiens des actualit√©s sur le Mounjaro (tirz√©patide), reformul√©s et traduits par intelligence artificielle. Pas de conseil m√©dical.</p></div><div class=footer-col><h4>Navigation</h4><ul><li><a href=/>Accueil</a></li><li><a href=/#newsletter>Newsletter</a></li><li><a href=https://mounjaronews.info/sitemap.xml target=_blank>Sitemap</a></li></ul></div><div class=footer-col><h4>Ressources</h4><ul><li><a href=https://www.mounjaro.com target=_blank rel=noopener>Mounjaro.com</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/?term=tirzepatide" target=_blank rel=noopener>PubMed</a></li><li><a href=https://www.ema.europa.eu target=_blank rel=noopener>EMA</a></li></ul></div></div><div class=footer-bottom><p class=footer-copy>&copy; 2026 Mounjaro News &nbsp;¬∑&nbsp;
Propuls√© par <a href=https://www.anthropic.com target=_blank rel=noopener style=color:rgba(255,255,255,.6)>Claude AI</a></p><p class=footer-disclaimer>‚ö†Ô∏è Site d'information uniquement ‚Äî pas de conseil m√©dical. Consultez toujours votre m√©decin.
For informational purposes only ‚Äî not medical advice.</p></div></div></footer></body></html>